Philips (NYSE: PHG) has unveiled a new ECG AI marketplace designed to centralize access to multiple AI-powered diagnostic tools for cardiac care teams. The platform enables U.S. hospitals and health systems to integrate validated algorithms seamlessly into existing Philips infrastructure, accelerating ECG result reviews and diagnoses.
By managing vendor connections within a single platform, Philips aims to reduce IT overhead and operational costs associated with handling multiple AI tool interfaces. The marketplace offers direct access to a broad portfolio of AI algorithms at the point of care.
Anumana is the first partner to adopt the marketplace, offering its FDA-cleared ECG-AI low ejection fraction (LEF) algorithm. This collaboration exemplifies Philips’ commitment to an open ecosystem, fostering innovation and early heart disease detection.
“Philips ECG AI Marketplace builds a more connected and flexible approach to cardiac care innovation,” said Stefano Folli, Philips business leader for Ambulatory Monitoring and Diagnostics.
Follow MEDWIRE.AI for the latest in cardiac AI technology.
